期刊
SYSTEMS BIOLOGY IN REPRODUCTIVE MEDICINE
卷 65, 期 3, 页码 205-213出版社
TAYLOR & FRANCIS INC
DOI: 10.1080/19396368.2018.1519047
关键词
Nanoparticles; lactoferrin; antiretroviral drugs; reproductive toxicity
资金
- Department of Biotechnology
- DST-Nanomission of Government of India
- Council for Scientific and Industrial Research, Government of India
- Indian Council of Medical Research
- University Grants Commission
Multiple prevention therapy has gained importance for the prevention and treatment of sexually transmitted diseases, especially HIV/AIDS. Antiretroviral drugs encapsulated in nanoparticles have been developed for efficient delivery of the drugs to the vaginal surface. Lactoferrin nanoparticles (LFNPs) encapsulating anticancer or antiretroviral drugs are found to be promising agents to specifically deliver drugs at the target sites. Recent studies indicate that the bioavailability is higher for antiretroviral drugs delivered by LFNPs than when the drugs are administered alone. Although LFNP-mediated drug delivery via the oral or vaginal route for the treatment of HIV/AIDS is promising, the effect of such administrations is not well studied. Drug-loaded LFNPs when administered to rats by the vaginal route did not show any effect on the reproductive performance, fertility, and postnatal development. Oral administration of drug-loaded LFNPs caused a significant decrease in litter size, whereas the reproductive performance and postnatal development remained normal. In our model system, the results indicate that vaginal administration of drug-loaded LFNPs appears safer and can be projected for the delivery of antiretroviral agents via the vaginal route.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据